Sectoral Asset Management Inc. Sells 404,312 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Sectoral Asset Management Inc. lowered its holdings in Privia Health Group, Inc. (NASDAQ:PRVAFree Report) by 81.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 90,310 shares of the company’s stock after selling 404,312 shares during the quarter. Sectoral Asset Management Inc.’s holdings in Privia Health Group were worth $2,080,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. Vanguard Group Inc. grew its position in Privia Health Group by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 11,003,989 shares of the company’s stock worth $253,092,000 after purchasing an additional 51,317 shares during the last quarter. Wellington Management Group LLP grew its position in Privia Health Group by 1.0% during the 3rd quarter. Wellington Management Group LLP now owns 4,656,685 shares of the company’s stock worth $107,104,000 after purchasing an additional 45,639 shares during the last quarter. Riverbridge Partners LLC grew its position in Privia Health Group by 8.7% during the 4th quarter. Riverbridge Partners LLC now owns 4,342,385 shares of the company’s stock worth $100,005,000 after purchasing an additional 348,852 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Privia Health Group by 2.8% in the 3rd quarter. Invesco Ltd. now owns 1,725,969 shares of the company’s stock valued at $39,697,000 after acquiring an additional 47,643 shares during the last quarter. Finally, Avidity Partners Management LP boosted its holdings in shares of Privia Health Group by 43.1% in the 3rd quarter. Avidity Partners Management LP now owns 1,545,100 shares of the company’s stock valued at $35,537,000 after acquiring an additional 465,294 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on PRVA. TD Cowen dropped their price objective on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating on the stock in a report on Friday, March 1st. Citigroup began coverage on shares of Privia Health Group in a report on Monday, April 22nd. They issued a “buy” rating and a $25.00 price objective on the stock. JPMorgan Chase & Co. decreased their target price on shares of Privia Health Group from $38.00 to $30.00 and set an “overweight” rating for the company in a research note on Wednesday, March 6th. Bank of America cut shares of Privia Health Group from a “buy” rating to a “neutral” rating and decreased their target price for the company from $27.00 to $21.00 in a research note on Thursday, February 22nd. Finally, Baird R W upgraded shares of Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th. Two investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.92.

Check Out Our Latest Report on PRVA

Insider Buying and Selling

In other news, Director Adam Boehler acquired 5,306 shares of the stock in a transaction on Wednesday, May 29th. The stock was bought at an average price of $16.50 per share, with a total value of $87,549.00. Following the completion of the transaction, the director now directly owns 5,773,158 shares of the company’s stock, valued at $95,257,107. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Adam Boehler acquired 5,306 shares of Privia Health Group stock in a transaction that occurred on Wednesday, May 29th. The shares were purchased at an average cost of $16.50 per share, for a total transaction of $87,549.00. Following the completion of the purchase, the director now directly owns 5,773,158 shares of the company’s stock, valued at approximately $95,257,107. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas A. Mccarthy acquired 10,000 shares of Privia Health Group stock in a transaction that occurred on Thursday, May 23rd. The shares were purchased at an average price of $16.37 per share, for a total transaction of $163,700.00. Following the completion of the purchase, the director now directly owns 52,611 shares of the company’s stock, valued at $861,242.07. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 292,871 shares of company stock valued at $4,739,475 and sold 49,390 shares valued at $897,700. Corporate insiders own 14.20% of the company’s stock.

Privia Health Group Trading Down 1.9 %

Shares of NASDAQ:PRVA traded down $0.34 on Friday, reaching $17.15. 496,975 shares of the company were exchanged, compared to its average volume of 1,069,466. The firm has a market cap of $2.05 billion, a price-to-earnings ratio of 114.33, a price-to-earnings-growth ratio of 2.57 and a beta of 0.78. The company has a 50-day moving average of $17.88 and a 200-day moving average of $20.26. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $29.42.

Privia Health Group (NASDAQ:PRVAGet Free Report) last announced its quarterly earnings data on Thursday, May 9th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.03). The company had revenue of $415.24 million for the quarter, compared to analysts’ expectations of $435.07 million. Privia Health Group had a return on equity of 3.13% and a net margin of 1.11%. As a group, analysts forecast that Privia Health Group, Inc. will post 0.21 earnings per share for the current year.

Privia Health Group Company Profile

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Stories

Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVAFree Report).

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.